- Home
- Applications
- north america
- viral infectious disease
Show results for
Refine by
Viral Infectious Disease Product Applications In North America
2 applications found
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
Velacur can also be used to assess and manage other chronic liver diseases, resulting from viral infections, autoimmune disorders, metabolic diseases or excessive alcohol consumption. Like fatty liver disease, viral and autoimmune hepatitis are “silent” diseases of the liver. They show no symptoms until your liver is severely damaged, making it vital for early disease detection to limit progression and protect the health of your ...
BySonic Incytes Medical Corp. based in Vancouver, BRITISH COLUMBIA (CANADA)